Quasi-Donai Patient Managers do not include physicians, nurses, or general service employees.
1. Physicians.
Quasi-Donai patient management personnel are not responsible for completing the diagnosis and treatment of diseases, but to assist doctors in completing related treatment measures and technical support. In addition to completing relevant medical management and patient education, quasi-donor patient managers also need to do a good job of disclosure and introduction of relevant information to assist patients to understand their own disease, and to guide patients on how to carry out effective self-management.
2. Nurses.
The work of quasi-drug-resistant patient managers emphasizes health management, disease prevention, and rehabilitation guidance for patients, which overlap with nurses' areas of specialization, but have very different work requirements and focuses. Quasi-donor patient managers need to help patients to do a good job of nursing care, to ensure that the patient's rehabilitation is actually improved and facilitated.
3. General service employees.
Quasi-donor patient management requires a full range of work, including medical, nutritional, nursing and other dimensions, and requires relevant professional training and knowledge background, while the general service employees do not have these professional knowledge and skills. At the same time, the professionalism, responsibility, and attention to detail required for quasi-donor patient management are not suitable for this type of staff.
Meaning of multidrug-resistant patients:
Multidrug-resistant patients (MDR patients) are patients who suffer from infections with multidrug-resistant bacteria, which refers to the phenomenon of bacteria that are resistant to different classes of broad-spectrum drugs. Once such drug-resistant bacteria enter the human body, the therapeutic effect of traditional antibiotics will be greatly reduced, leading to persistent, developing and worsening infections, and even life-threatening.
Patients with multi-resistance are infected with bacteria after undergoing procedures such as surgery, incision, catheterization, dialysis and other diagnostic and therapeutic procedures in hospitals and other healthcare facilities, or it may be due to the use of antibiotic abuse leading to a vicious cycle of overgrowth of normal microorganisms such as the intestinal tract and pathogenic bacteria. The incidence of multiresistant patients is increasing year by year, and has become a global public ****health problem that places a great burden on healthcare organizations and society as a whole.
The treatment of multi-resistant patients is difficult, the drug treatment cycle is long and expensive, treatment often fails, and the condition is prone to recurring episodes, which can even be life-threatening. In order to avoid the occurrence of multi-resistant patients and cut down the burden it brings to hospitals, it is necessary to strengthen the management of medical institutions, enhance the publicity and education of patients, promote the rational use of antibiotics and accelerate the research and development of new antimicrobial drugs.